1460P IO-Synthesise RCC: Analysis of real-world (RW) health-related quality of life (HRQoL) outcomes with nivolumab for previously treated metastatic renal cell carcinoma (mRCC) using pooled data from France and Germany

Authors :: G. Mouillet
J. Bedke
L. Albiges
P. Barthelemy
B. Escudier
V. Gruenwald
P. Ivanyi
H. Mueller-Huesmann
Y-A. Vano
E. von der Heyde
F. Ejzykowicz
F. Brellier
M. Herber
C. Quentric
B.M. Bennett
S. Nere
A. Autengruber
A. Thiery-Vuillemin
M-O. Grimm
Source :: Annals of Oncology. 33:S1212-S1213
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools